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Governments seeking to implement public health policy often face intense 
lobbying from industries vying to protect commercial interests. We spoke to 
Verity Firth, former Deputy Lord Mayor of Sydney and NSW Labor Minister 
(2007–2011), about her experiences to gain insights into ways in which 
governments can strike the right balance to deliver better health and 
social outcomes, and how public health advocates can ensure their voices 
are heard.
Q: In your experience in Australian local and state government, to what 
extent have you seen the influence of commercial interests play a role in 
shaping health and social policy? How much did health and social policy 
rate as a concern for political decision makers?
A: Locally and at state level there were differences. As a councillor with the 
City of Sydney, it was a topic of significant concern, probably less so about 
the harm being caused to individuals and more about public safety and 
public amenity. There were big debates about issues like alcohol-free zones 
and strong support for safe injecting rooms. Various industry associations, 
such as those representing liquor licence holders, obviously lobbied hard on 
certain initiatives. 
In State Parliament, it was still a concern, but as a minister it was closely 
linked to your portfolio. Ministers that were in portfolios where there was a 
significant impact – for example health or family and community services or 
housing – were much more likely to be concerned about health and social 
policy than if you had a portfolio like transport.
Whether ministers saw health issues as an individual problem or as a 
problem shaped by commercial interests depended a little bit on their politics, 
and their philosophical or ideological outlook.
Q: How did health issues that had commercial connections rank in terms 
of importance for government action? For example, you did a lot in 
tobacco control – did you have to convince your colleagues this was a 
good way to go or did you receive strong support?
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• Politicians face intense lobbying from
industry and corporate interests regarding
public health reforms that impact
commercial interests
• Having well-resourced ‘boutique portfolios’
in government that are focused on specific
public health issues (e.g. cancer) gives
politicians a stronger platform to promote
health reforms
• Real reform involves a collective effort.
The government can work alongside
philanthropic organisations and others,
such as academics, to win public support
for new heath policy in the face of
commercial opposition
• Public health advocates can take
advantage of opportunities for reform
when cash-strapped governments are
keen to introduce visionary policies
that don’t require funds, but will win public
favour
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A: I think it helped that we had a dedicated Minister for 
Cancer in NSW, and with that portfolio came the Cancer 
Institute1, which was separate from the Department of 
Health, and had a $100m budget of its own. The fact that 
there was a resourced body that was able to concentrate 
on issues of cancer prevention and treatment meant that I 
had much more of a platform than I would otherwise have 
had. And I had the resource of expertise at my fingertips 
to provide the evidence. The way the portfolios were 
set up had a big impact on how I was then able to get 
smoking to the fore in a Cabinet debate. 
Q: Is having health-related portfolios with dedicated 
funds and staff one of the best ways for governments 
to combat commercial interests? 
A: In a portfolio like health, which is so enormous and in 
which you are dealing with urgent problems every day, 
having something like a specific prevention body for 
cancer is helpful. It is otherwise hard to find airtime in the 
midst of the immediacy of concerns of the large-scale 
public health system. The idea of ‘boutique portfolios’ 
around public health issues was a good structure. 
Q: Do you think political decision makers are currently 
striking the right balance between market freedoms 
and individual and community wellbeing?
A: I think Australians are more relaxed about being 
regulated than other countries. Although people might 
complain about the ‘nanny state’, on the whole we don’t 
mind regulation the way the Americans do. 
The issue of resources is important. If you are going 
to get the right balance, then you do need to resource 
organisations solely for public benefit. You can’t have 
a highly resourced corporate sector and not have a 
reasonably resourced public benefit side…. because 
otherwise it will get completely skewed. However, when 
you combine both our bureaucratic capacity and also 
the capacity of some of our large-scale philanthropic 
organisations like the Cancer Council, we are able to 
achieve that balance in terms of the politicking around 
public health issues.  
Q: In your political career, did you have to navigate a 
situation where a change you were working towards 
came under opposition from commercial interests?
A: Absolutely. We introduced the Public Health (Tobacco) 
Act2 which saw a ban on the display of tobacco products 
and non-tobacco smoking accessories in shops, the 
single point of sale in larger retail outlets and the ban 
on smoking in cars with kids in 2009, and it was the first 
time I’d ever encountered the tobacco industry. They did 
come out and lobby us. They took other members of the 
Government out to lunch, they lobbied the backbench. 
I can’t even remember particularly what their arguments 
were; it was a general effect that ‘here we are, we’re here 
to be heard’. The other group we really had to contend 
with were the retailers’ associations. At least they were 
more upfront about what they wanted – they were saying 
this is a problem for us because it will impact on our 
sales. Both the tobacco industry and retailer lobby did 
their organising in local seats as well, so both those 
corporate interests absolutely played the political game. 
There was significant opposition.
Q: Did the commercial interests have any chance of 
watering down the legislation?
A: I don’t think anyone was at all convinced by the 
tobacco industry’s arguments. The retailers’ bodies 
had more influence, because there was a sympathetic 
response in the sense that they weren’t producing the 
cigarettes, they were just selling the cigarettes, and the 
small retailers included many struggling ‘mum and dad’ 
businesses. I think they got greater traction but in the 
end, they weren’t able to water down what we did. They 
were able to delay the inevitable, in that we gave a longer 
lead-in time for smaller retailers so they had more time 
to adjust.
Q: What lessons would you would pass on to 
other policy makers regarding contending with the 
commercial sector when trying to deliver effective 
public health policy?
A: The biggest thing I learnt from introducing the Public 
Health (Tobacco) Act2 was the power of coalitions. 
We had genuine consultation and were always very 
transparent and open about what we intended and 
wanted to do. Stakeholders, including the tobacco 
industry and retailers, had an opportunity to make 
their contributions. 
There was also a sense of civil society momentum. 
There was a group of people who wanted to make 
this reform happen and they were prepared to work 
collaboratively. The Cancer Council ran a fantastic 
grassroots campaign on smoking in cars with children, 
and they went out and got their staff and volunteers 
active, for example by visiting schools. We also had 
academics writing opinion pieces and running the 
evidence-based argument. These efforts strengthened my 
position in the Government considerably. It’s a collective 
effort and no one politician or no one agency can do it 
alone when you’re trying to achieve real reform. 
Q: Was being able to demonstrate public support 
important?
A: Yes. It’s both the demonstration of public opinion 
but also the actual winning of public opinion. You’re 
winning hearts and minds, as well as then demonstrating 
that the public is on your side and that is obviously 
powerful politically.
Q: What’s your advice for public health advocates 
to counter commercial interests and contribute to 
effective policy that improves health outcomes? 
A: I think to win heart and minds, you need to be careful 
about how you are coming across. It’s about the tone 
that you use, and particularly in issues involving parents 
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Q: Can there be genuine partnerships between public 
health and commercial interests to achieve reform?
A: When issues are negotiated between the two parties, 
in most cases, public health will probably get the rough 
end of the stick because public health will not be as 
well-resourced and able to pursue its interests. But that 
is where, I would argue, it is the role of government to 
step in. 
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making decisions for their children, you do need to get 
that tone right. People get so defensive, especially if they 
are told they are doing something bad for their children. It 
is about saying we’re here alongside you.
The other thing, which probably isn’t said much, is 
that sometimes when governments don’t have any money 
but need to do something that looks visionary, they’ll do 
a public health initiative – legislating or regulating doesn’t 
necessarily cost anything.
If the government feels it can win some brownie 
points with the electorate, for example through a policy 
like banning smoking in cars, then it’s an easy win. As 
public health advocates, it’s about finding those creative 
opportunities that can also induce behavioural change.
Q: Do you think there are ‘win-win’ scenarios for 
public health and commercial interests? Is there a way 
for them to work collaboratively?
A: I think commercial interests do have a sense of 
where something’s heading, and often it would be in 
their interests to work more closely with public health 
advocates. But that takes a company that has either a 
sense of public purpose in and of itself, or a company 
that’s able to read the lay of the land a bit better. For 
example, if you were an asbestos producer in the 1930s, 
and you’d been able to see what was coming, there’s 
all sorts of things you could have done that would both 
protect your bottom line as well as achieve a better public 
health outcome. 
The second thing is for commercial interests to 
consider is that just because it’s the way something is, 
doesn’t mean it’s the way something always will be. For 
example, when we were first banning smoking in pubs, 
you would have thought that the entire pub industry 
was going to collapse overnight. They were really fierce 
lobbyists. But think about it now – it is no problem at all 
and I would actually argue that we’ve probably extended 
pubs’ lifespan or their capacity to attract new markets well 
into the future, far more than their own silly short-sighted 
behaviour would have had them do.
I think these things can totally be a ‘win win’, but it 
does require some innovative thinking, sometimes on 
behalf of the commercial interests and potentially on 
behalf of the public health interests as well. 
